In addition to hemolysis, acquired hypercoagulability induced several hemostatic changes like TF and phospholipid overexpression, endothelial dysfunction and anticoagulant pathways, with decreased protein S and protein C (5). The gene discussed is PROS1; the disease is endothelial dysfunction.